7/11/26
MEDICINE MAN TECHNOLOGIES (SHWZ) Thesis: The company's significant losses and high debt levels are raising concerns among investors, especially in light of increased competition and declining wholesale prices.
★ Analysts see FY2025 revenue reaching $195M — +11.6% growth in a single year.
What Moves the Stock 1 Changes in state-level cannabis regulations impacting market access 2 Fluctuations in wholesale cannabis prices due to supply-demand dynamics 3 Consumer sentiment and trends in cannabis consumption 4 Expansion into new markets or states 5 Retail sales from dispensaries (approx. 60%) 6 Wholesale cannabis products (approx. 30%) 7 Consulting and licensing services (approx. 10%) 8 Growing acceptance and legalization of cannabis across the U.S. -0.0 0.0 0.0 0.0 0.0 0.00 SHWZ Daily 0.00 Feb '26 Apr '26 May '26 Jul '26
My Notes "Management noted, 'We are facing unprecedented challenges in maintaining margins amidst a rapidly evolving market landscape.'" Moat: The company's established brand and operational expertise provide a moderate level of competitive advantage… growth - investors looking for exposure to the expanding cannabis market and potential for high returns. Interest rates affect the company's borrowing costs, particularly given its high debt/equity ratio of 1.61… Watch on earnings: Wholesale cannabis price trends, Colorado cannabis sales data, Regulatory changes in cannabis legislation. One Sentence Summary: Medicine Man Technologies: the story is balanced — changes in state-level cannabis regulations impacting market access.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.